Cowen and Company’s Celgene Corp CELG Stock Holding History

Cowen and Company’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,364	Closed	-$2.32M	–	714
2019 Q3	$2.32M	Buy	+23,364	New	+$2.22M	0.59%	30

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Cowen and Company's CELG Position: Q4 2019 in Review

Cowen and Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,364 shares — an estimated $2.32M sold.

Cowen and Company first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $2.32M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Cowen and Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Cowen and Company sold 23,364 Celgene Corp shares in Q4 2019, an estimated $2.32M.
Cowen and Company first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
Cowen and Company's Celgene Corp position peaked at $2.32M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cowen and Company's 13F filing for Q4 2019, filed 11 Feb 2020.